Latest & greatest articles for HIV Test

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on HIV Test or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on HIV Test and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for HIV Test

81. A systematic review on uptake and yield of HIV self-testing among adults in Africa

A systematic review on uptake and yield of HIV self-testing among adults in Africa Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing (...) models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis by dividing the number of animals in the control group by the number of treatment groups served. Where applicable, Holm-Bonferroni correction for testing multiple

2015 PROSPERO

82. Barriers and facilitators to HIV testing in people age 50 and above: a systematic review

Barriers and facilitators to HIV testing in people age 50 and above: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing (...) models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis by dividing the number of animals in the control group by the number of treatment groups served. Where applicable, Holm-Bonferroni correction for testing multiple

2015 PROSPERO

83. Rapid point of care combined Antigen/Antibody HIV test to aid in the diagnosis of HIV infection

Rapid point of care combined Antigen/Antibody HIV test to aid in the diagnosis of HIV infection 1 Public Summary Document Application No. 1391 – Rapid point-of-care combined Antigen/Antibody HIV test to aid in the diagnosis of HIV infection Applicant: ANZPI, Alere Pty Ltd Date of MSAC consideration: MSAC 64 th Meeting, 30-31 July 2015 Context for decision: MSAC makes its advice in accordance with its Terms of Reference, see at www.msac.gov.au. 1. Purpose of application and links to other (...) applications An application was submitted by Inverness Medical Innovations Australia Pty Ltd for MBS listing of a rapid point-of-care combined Antigen/Antibody test for diagnosis of human immunodeficiency virus (HIV) infection for use in GP and sexual health clinics. The test for HIV infection is intended to be used in individuals where an HIV test is indicated and in those who are at high-risk of HIV infection. The evidence for assessment of this application was submitted in May 2015. 2. MSAC’s advice

2015 Medical Services Advisory Committee

84. Time period for HIV testing (HIV window period)

Time period for HIV testing (HIV window period) application/vnd.openxmlformats-officedocument.wordprocessingml.document

2014 British Association for Sexual Health and HIV

85. Effect of Optional Home Initiation of HIV Care Following HIV Self-testing on Antiretroviral Therapy Initiation Among Adults in Malawi: A Randomized Clinical Trial. Full Text available with Trip Pro

Effect of Optional Home Initiation of HIV Care Following HIV Self-testing on Antiretroviral Therapy Initiation Among Adults in Malawi: A Randomized Clinical Trial. Self-testing for HIV infection may contribute to early diagnosis of HIV, but without necessarily increasing antiretroviral therapy (ART) initiation.To investigate whether offering optional home initiation of HIV care after HIV self-testing might increase demand for ART initiation, compared with HIV self-testing accompanied (...) by facility-based services only.Cluster randomized trial conducted in Blantyre, Malawi, between January 30 and November 5, 2012, using restricted 1:1 randomization of 14 community health worker catchment areas. Participants were all adult (≥16 years) residents (n = 16,660) who received access to home HIV self-testing through resident volunteers. This was a second-stage randomization of clusters allocated to the HIV self-testing group of a parent trial.Clusters were randomly allocated to facility-based

2014 JAMA Controlled trial quality: predicted high

86. HIV prevalence and testing among street-involved youth in Ontario

HIV prevalence and testing among street-involved youth in Ontario Rapid Review #81: April 2014 HIV prevalence and testing among street-involved youth in Ontario Questions ? What is the prevalence of HIV among street-involved youth in Ontario and Canada? ? To which risk groups do these youth belong? ? What street-involved youth-specific testing interventions have been conducted? ? What is the seropositivity rate found in these testing interventions? Key Take-Home Messages ? Although the evidence (...) -reviewed literature on testing interventions for street-involved youth in Canada; however some interventions conducted in the US demonstrate that youth preferred to get their testing results over the phone rather than face to face, and that peer supported case management models can help attract more youth to testing, and link them to ongoing health care (11;12). © Ontario HIV Treatment Network ~ 1300 Yonge Street Suite 600 Toronto Ontario M4T 1X3 p. 416 642 6486 | 1-877 743 6486 | f. 416 640 4245

2014 Ontario HIV Treatment Network

87. The clinical effectiveness of behaviour change interventions to reduce risky sexual behaviour after a negative HIV test in men who have sex with men (MSM): a systematic review

The clinical effectiveness of behaviour change interventions to reduce risky sexual behaviour after a negative HIV test in men who have sex with men (MSM): a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email (...) by the number of treatment groups served. Where applicable, Holm-Bonferroni correction for testing multiple subgroup analyses will be performed. If one or more subgroup analyses cannot be performed due to insufficient data, the p-value will be adjusted accordingly. ">Other Subgroup analysis or meta-regression are used to explore between-study heterogeneity and can provide insight into the relationship between study characteristics (e.g. species, sex or drug class or dose) and effect size. They should

2014 PROSPERO

88. Accuracy of 4th generation rapid diagnostic tests for HIV infection: a systematic review and meta-analysis

Accuracy of 4th generation rapid diagnostic tests for HIV infection: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation (...) -Bonferroni correction for testing multiple subgroup analyses will be performed. If one or more subgroup analyses cannot be performed due to insufficient data, the p-value will be adjusted accordingly. ">Other Subgroup analysis or meta-regression are used to explore between-study heterogeneity and can provide insight into the relationship between study characteristics (e.g. species, sex or drug class or dose) and effect size. They should be considered hypothesis-generating. Ideally, a threshold describing

2014 PROSPERO

89. Rapid blood test device for HIV, HBV, HCV, &amp syphillis

Rapid blood test device for HIV, HBV, HCV, & syphillis Rapid blood test device for HIV, HBV, HCV, & syphillis Rapid blood test device for HIV, HBV, HCV, & syphillis Malaysian Health Technology Assessment (MaHTAS) Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Malaysian Health Technology Assessment (MaHTAS). Rapid blood test device (...) for HIV, HBV, HCV, & syphillis . Putrajaya: Malaysian Health Technology Assessment (MaHTAS). 2014 Authors' objectives To assess the effectiveness, safety and cost-effectiveness of the rapid blood test device (BPC Labmen 4 in 1 RDT) for HIV, HBV, HCV, & Syphillis for the rapid diagnosis of human immunodeficiency virus (HIV), hepatitis B (HBV), hepatitis C (HCV), and syphillis. Authors' conclusions There was no retrievable scientific evidence or clinical studies to support the efficacy / effectiveness

2014 Health Technology Assessment (HTA) Database.

90. A systematic review of the impact of social structural factors on attitudes to HIV testing in Africa

A systematic review of the impact of social structural factors on attitudes to HIV testing in Africa Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web (...) models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis by dividing the number of animals in the control group by the number of treatment groups served. Where applicable, Holm-Bonferroni correction for testing multiple

2014 PROSPERO

91. HIV testing

HIV testing HIV testing | Advice | NICE HIV testing Local government briefing [LGB21] Published date: June 2014 Advice Between 2012 and 2015 we developed a series of local government briefings for a range of public health topics. We no longer have the capacity to maintain these to an acceptable standard and the information is now out of date, so these were removed from our website on 30 March 2018 . Explore © NICE [year]. All rights reserved. Subject to .

2014 National Institute for Health and Clinical Excellence - Advice

92. Randomised clinical trial: Brief, patient-centred risk-reduction counselling at the time of a rapid HIV test does not affect subsequent acquisition of sexually transmitted infections

Randomised clinical trial: Brief, patient-centred risk-reduction counselling at the time of a rapid HIV test does not affect subsequent acquisition of sexually transmitted infections Brief, patient-centred risk-reduction counselling at the time of a rapid HIV test does not affect subsequent acquisition of sexually transmitted infections | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via (...) at the time of a rapid HIV test does not affect subsequent acquisition of sexually transmitted infections Article Text Prevention Randomised clinical trial Brief, patient-centred risk-reduction counselling at the time of a rapid HIV test does not affect subsequent acquisition of sexually transmitted infections Caitlin E Kennedy Statistics from Altmetric.com Commentary on: Metsch LR , Feaster DJ , Gooden L , et al. Effect of risk-reduction counseling with rapid HIV testing on risk of acquiring sexually

2014 Evidence-Based Medicine

93. HIV testing guidelines for children of HIV positive parents and/or siblings in the UK and Ireland

HIV testing guidelines for children of HIV positive parents and/or siblings in the UK and Ireland application/msword

2014 The Children's HIV Association

94. Updating the HIV-Testing Guidelines - A Modest Change with Major Consequences. Full Text available with Trip Pro

Updating the HIV-Testing Guidelines - A Modest Change with Major Consequences. 23425132 2013 03 14 2013 03 07 1533-4406 368 10 2013 Mar 07 The New England journal of medicine N. Engl. J. Med. Updating the HIV-testing guidelines--a modest change with major consequences. 884-6 10.1056/NEJMp1214630 Martin Erika G EG Rockefeller College of Public Affairs and Policy and the Nelson A. Rockefeller Institute of Government, University at Albany-State University of New York, Albany, USA. Schackman Bruce (...) R BR eng Journal Article 2013 02 20 United States N Engl J Med 0255562 0028-4793 AIM IM Adolescent Adult Advisory Committees Aged Early Diagnosis HIV Infections diagnosis Health Care Costs Humans Insurance, Health, Reimbursement economics Mass Screening economics standards Middle Aged Practice Guidelines as Topic United States Young Adult 2013 2 22 6 0 2013 2 22 6 0 2013 3 15 6 0 ppublish 23425132 10.1056/NEJMp1214630

2013 NEJM

95. Routine HIV Testing, Public Health, and the USPSTF - An End to the Debate. Full Text available with Trip Pro

Routine HIV Testing, Public Health, and the USPSTF - An End to the Debate. 23425134 2013 03 14 2013 03 07 1533-4406 368 10 2013 Mar 07 The New England journal of medicine N. Engl. J. Med. Routine HIV testing, public health, and the USPSTF--an end to the debate. 881-4 10.1056/NEJMp1214535 Bayer Ronald R Center for the History and Ethics of Public Health, Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, USA. Oppenheimer Gerald M GM eng Journal (...) Article 2013 02 20 United States N Engl J Med 0255562 0028-4793 AIM IM Advisory Committees Centers for Disease Control and Prevention (U.S.) Early Diagnosis HIV Infections diagnosis Humans Mass Screening standards Practice Guidelines as Topic United States 2013 2 22 6 0 2013 2 22 6 0 2013 3 15 6 0 ppublish 23425134 10.1056/NEJMp1214535

2013 NEJM

96. Voluntary counselling and testing plus information distribution to reduce HIV-related risk behaviours among Hong Kong male cross-border truck drivers: a randomised controlled study. (Abstract)

Voluntary counselling and testing plus information distribution to reduce HIV-related risk behaviours among Hong Kong male cross-border truck drivers: a randomised controlled study. 22865223 2013 02 06 2018 12 01 1024-2708 18 Suppl 3 2012 Aug Hong Kong medical journal = Xianggang yi xue za zhi Hong Kong Med J Voluntary counselling and testing plus information distribution to reduce HIV-related risk behaviours among Hong Kong male cross-border truck drivers: a randomised controlled study. 39-41 (...) Lau J T F JT Centre for Health Behaviours Research, School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong SAR, China. jlau@cuhk.edu.hk Tsui H Y HY eng Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't China Hong Kong Med J 9512509 1024-2708 IM Adolescent Adult Condoms statistics & numerical data Counseling HIV Infections prevention & control Health Education Health Knowledge

2013 Hong Kong medical journal = Xianggang yi xue za zhi Controlled trial quality: uncertain

97. Telephone communication of HIV testing results for improving knowledge of HIV infection status. (Abstract)

Telephone communication of HIV testing results for improving knowledge of HIV infection status. This is one of three Cochrane reviews that examine the role of the telephone in HIV/AIDS services. Both in developed and developing countries there is a large proportion of people who do not know they are infected with HIV. Knowledge of one's own HIV serostatus is necessary to access HIV support, care and treatment and to prevent acquisition or further transmission of HIV. Using telephones instead (...) of face-to-face or other means of HIV test results delivery could lead to more people receiving their HIV test results.To assess the effectiveness of telephone use for delivery of HIV test results and post-test counselling.To evaluate the effectiveness of delivering HIV test results by telephone, we were interested in whether they can increase the proportion of people who receive their HIV test results and the number of people knowing their HIV status.We searched The Cochrane Central Register

2013 Cochrane

98. Systematic review on the use of Rapid HIV test in areas of high HIV prevalence - role of a dental surgeon.

Systematic review on the use of Rapid HIV test in areas of high HIV prevalence - role of a dental surgeon. Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation (...) -Bonferroni correction for testing multiple subgroup analyses will be performed. If one or more subgroup analyses cannot be performed due to insufficient data, the p-value will be adjusted accordingly. ">Other Subgroup analysis or meta-regression are used to explore between-study heterogeneity and can provide insight into the relationship between study characteristics (e.g. species, sex or drug class or dose) and effect size. They should be considered hypothesis-generating. Ideally, a threshold describing

2013 PROSPERO

99. Challenges and barriers in the widespread implementation of HIV rapid and point-of-care tests: a systematic review

Challenges and barriers in the widespread implementation of HIV rapid and point-of-care tests: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence (...) -Bonferroni correction for testing multiple subgroup analyses will be performed. If one or more subgroup analyses cannot be performed due to insufficient data, the p-value will be adjusted accordingly. ">Other Subgroup analysis or meta-regression are used to explore between-study heterogeneity and can provide insight into the relationship between study characteristics (e.g. species, sex or drug class or dose) and effect size. They should be considered hypothesis-generating. Ideally, a threshold describing

2013 PROSPERO

100. Demographic Characteristics Associated with Access to HAART, HIV Care and HIV Viral Load Testing

Demographic Characteristics Associated with Access to HAART, HIV Care and HIV Viral Load Testing Rapid Review #62: November 2012 Demographic characteristics associated with access to HAART, HIV care and HIV viral load testing Questions 1. In Canada, is access to HAART/ARV therapy associated with demographic characteristics of PHAs? 2. In Canada, is access to HIV viral load testing, or HIV medical care in keeping with established guidelines and standards, associated with demographic (...) the barriers to accessing HAART given the financial barriers that some may face in accessing treatment. ? The demographic factors associated with adherence to HAART have been studied more fully and may be more applicable to the Canadian context where, theoretically, everyone has access to HAART. ? There are a large number of people with HIV who do not undergo viral load testing or CD4 cell count monitoring according to established guidelines, but most people access HIV care within one month of initial

2013 Ontario HIV Treatment Network